HIV Pulse

Women make up approximately 18% of the population living with HIV in British Columbia. Women living with HIV can face unique barriers to care and challenges adhering to antiretroviral therapy (ART), compared with men. As a result, women often are not fully benefitting from the life-saving treatment available to them. In this issue of the […]

The HIV Cascade of Care (also known as Care Continuum) provides a framework for service providers and policymakers to measure progress according to steps in the delivery of HIV treatment and care. It allows us to assess development towards HIV prevention and care goals, identifying gaps in sustained patient care. In this volume of HIV […]

Youth represent a growing number of HIV cases in Canada; according to the Public Health Agency of Canada, of 71,300 people living with HIV in Canada, approximately 25% are youth. Many struggle with access to, and retention in, HIV-care due to multiple barriers. In this volume of HIV Pulse, we explore the characteristics of HIV-positive […]

Disparities in access to HIV care and treatment, including access to antiretroviral (ARV)-prescribing physicians, exist in Canada. This HIV Pulse measures the number of ARV-prescribing physicians by region in BC and outlines their characteristics. Profiled here are those who prescribed ARVs between January 1, 2013 – December 31, 2013, based on the data from the […]

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below